Elafibranor for the treatment of NAFLD: One pill, two molecular targets and multiple effects in a complex phenotype

Sookoian, Silvia Cristina; Pirola, Carlos José

info:eu-repo/semantics/article

Fecha

2016-05

Registro en:

Sookoian, Silvia Cristina; Pirola, Carlos José; Elafibranor for the treatment of NAFLD: One pill, two molecular targets and multiple effects in a complex phenotype; Mexican Association of Hepatology; Annals of Hepatology; 15; 4; 5-2016; 604-609

1665-2681

http://hdl.handle.net/11336/39854

CONICET Digital

CONICET

https://repositorioslatinoamericanos.uchile.cl/handle/2250/4407891

Autor

Sookoian, Silvia Cristina

Pirola, Carlos José

Institución

Consejo Nacional de Investigaciones Científicas y Tecnológicas (Argentina)

Resumen

Article commented: Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.

Materias

Nafld

Nash

Treatment

Elafibranor

Mostrar el registro completo del ítem